This is analogous to the evidence pathway followed for liraglutide (LEADER trial, NEJM 2016) and semaglutide (SUSTAIN-6 trial, NEJM 2016), which established cardiovascular benefit for those agents only after large, long-term CVOTs reported [6] The heart rate increase warrants ongoing surveillance, particularly in patients with pre-existing cardiac conditions Phase 3 trials are currently underway (see ClinicalTrials.gov and the EU Clinical Trials Information System, CTIS, for registered studies)
[DOI] [PubMed] [Google Scholar] 39.Drtilkova I., Sery O., Theiner P., Uhrova A., Zackova M., Balastikova B., Znojil V
It is well-known that GLP-1 is strongly secreted in response to the intake of macronutrients, including carbohydrates, proteins, and lipids
Tesamorelin/Ipamorelin Potential Synergy: Combining Tesamorelin and Ipamorelin may lead to a more sustained and controlled release of growth hormone due to their different mechanisms of action
Healthier skin and hair: GHKCu supports collagen and elastin for firmer-looking skin and encourages healthier hair